89Bio Gross Margin

The Gross Margin of 89Bio Inc (ETNB) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

89Bio Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

89Bio Gross Margin - Peers Comparison

Ticker	Name	Value
AMGN	Amgen Inc	61.53%
APLT	Applied Therapeutics Inc	7775.20%
AVRO	AVROBIO Inc	7775.20%
OCX	OncoCyte Corp	39.34%
SPRO	Spero Therapeutics Inc	7775.20%
VKTX	Viking Therapeutics Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
950220.KQ	Neoimmunetech Inc	7775.20%
ACET	Adicet Bio Inc	7775.20%
APS.TO	Aptose Biosciences Inc	100.00%
AUTL	Autolus Therapeutics PLC	-6.37%
BYSI	Beyondspring Inc	7775.20%
GMDA	Gamida Cell Ltd	18.50%
MRNA	Moderna Inc	70.06%
SNSE	Sensei Biotherapeutics Inc	7775.20%
950200.KQ	Psomagen Inc	23.13%
CRNX	Crinetics Pharmaceuticals Inc	7775.20%
NLTX	Neoleukin Therapeutics Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
950160.KQ	Kolon TissueGene Inc	11.72%
AGLE	Aeglea Bio Therapeutics Inc	7775.20%
ALDX	Aldeyra Therapeutics Inc	7775.20%
GERN	Geron Corp	98.37%
GILD	Gilead Sciences Inc	78.26%
BCYC	Bicycle Therapeutics PLC	7775.20%
INZY	Inozyme Pharma Inc	7775.20%
SPRB	Spruce Biosciences Inc	7775.20%
ABBV	Abbvie Inc	69.99%
SELB	Selecta Biosciences Inc	7775.20%
BLU.TO	BELLUS Health Inc	7775.20%
FHTX	Foghorn Therapeutics Inc.	7775.20%
ISEE	IVERIC bio Inc	7775.20%
ONCT	Oncternal Therapeutics Inc	91.24%
RAPT	Rapt Therapeutics Inc	7775.20%
SMMT	Summit Therapeutics Inc	99.95%